
Mutating the enzyme at the heart of the CRISPR gene editing system can improve its fidelity.
CREDIT: DataBase Center for Life Science (DBCLS)
The CRISPR system is a powerful tool for the targeted editing of genomes, with significant therapeutic potential, but runs the risk of inappropriately editing “off-target” sites. However, a new study publishing July 9, 2020 in the open-access journal PLOS Biology by Feng Gu of Wenzhou Medical University, China, and colleagues, shows that mutating the enzyme at the heart of the CRISPR gene editing system can improve its fidelity. The results may provide a therapeutically safer strategy for gene editing than using the unmodified enzyme system.
The CRISPR system employs an enzyme called Cas9 to cleave DNA. Cas9 will cut almost any DNA sequence. Its specificity comes from its interaction with a “guide RNA” (gRNA) whose sequence allows it to bind with the target DNA through base-pair matching. Once it does, the enzyme is activated and the DNA is cut.
The CRISPR system is found in multiple bacterial species; among those commonly used in research, that from Staphylococcus aureus has the advantage of size–unlike some others, its gene is small enough to fit inside a versatile and harmless gene therapy vector called adeno-associated virus, making it attractive for therapeutic purposes.
A key limitation of any of the CRISPR systems, including that from S. aureus, is off-target cleavage of DNA. A guide RNA may bind weakly to a site whose sequence is a close but imperfect match; depending on how close the match is and how tightly the enzyme interacts with the paired gRNA-DNA complex, the enzyme may become activated and cut the DNA wrongly, with potentially harmful consequences.
To explore whether the S. aureus Cas9 could be modified to cleave with higher fidelity to the intended target, the authors generated a range of novel Cas9 mutants and tested their ability to discriminate against imperfect matches while retaining high activity at the intended site. They found one such mutant, which distinguished and rejected single base-pair mismatches between gRNA and DNA, regardless of the target, increasing the fidelity up to 93-fold over the original enzyme. They showed that the mutation affected part of the recognition domain, the region of the enzyme that coordinates contacts between the enzyme and the gRNA-DNA complex. The mutation had the likely effect of weakening those contacts, thus ensuring that only the strongest pairing–which would come from a perfect sequence match–would trigger enzyme activity.
“Avoidance of off-target cleavage is a crucial challenge for development of CRISPR for medical interventions, such as correcting genetic diseases or targeting cancer cells,” Gu said. “Our results point the way to developing potentially safer gene therapy strategies.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
CRISPR gene editing
- How CRISPR gene-editing tech could be used to run rapid COVID tests at homeon February 22, 2021 at 2:30 pm
While the nation’s COVID-19 testing network is more robust than it was in early in the pandemic, the promise of rapid tests at home has yet to be realized. But scientists say that CRISPR, the ...
- CRISPR study transfers genes between poultry breedson February 22, 2021 at 8:40 am
Researchers at the University of Edinburgh used the gene editing approach CRISPR to transfer beneficial traits – like climate-tolerant feathers or disease resistance– between chicken breeds.
- Tweaking corn kernels with CRISPRon February 22, 2021 at 8:22 am
Corn has a highly complex genome, making it a challenge to apply genome-editing techniques to it. CSHL Professor David Jackson and postdoctoral fellow Lei Liu used CRISPR to tinker with the corn ...
- After the Nobel, what next for Crispr gene-editing therapies?on February 21, 2021 at 1:13 am
Hailed as the ‘molecular scissors’ that will allow us to rewrite our genes, the DNA tool is being trialled in treatments for everything from sickle-cell anaemia to cancer ...
- What Gene Editing Can Do for Humankindon February 19, 2021 at 7:58 am
The new biotechnology called CRISPR offers the prospect of defeating lethal viruses and curing genetic diseases, even as it raises serious moral questions.
Go deeper with Google Headlines on:
CRISPR gene editing
Go deeper with Bing News on:
CRISPR
- How CRISPR gene-editing tech could be used to run rapid COVID tests at homeon February 22, 2021 at 2:30 pm
While the nation’s COVID-19 testing network is more robust than it was in early in the pandemic, the promise of rapid tests at home has yet to be realized. But scientists say that CRISPR, the ...
- Enhancing grain-yield-related traits by CRISPR–Cas9 promoter editing of maize CLE geneson February 22, 2021 at 10:25 am
Two gene editing strategies for engineering quantitative variation of yield-related traits in maize are demonstrated: creating promoter-edited weak alleles of CLE genes or null alleles of redundant ...
- CRISPR & Cas Genes Market Analysis, Trends, Scope, Regional Estimation, Company Profiles and Forecast 2020 to 2027on February 22, 2021 at 9:47 am
This report covers the current ground scenario and the future progress projections of the CRISPR & Cas Genes industry for 2016-2027 along with the in-depth competitor analysis. Our research report ...
- CRISPR study transfers genes between poultry breedson February 22, 2021 at 8:40 am
Researchers at the University of Edinburgh used the gene editing approach CRISPR to transfer beneficial traits – like climate-tolerant feathers or disease resistance– between chicken breeds.
- Tweaking corn kernels with CRISPRon February 22, 2021 at 8:22 am
Corn has a highly complex genome, making it a challenge to apply genome-editing techniques to it. CSHL Professor David Jackson and postdoctoral fellow Lei Liu used CRISPR to tinker with the corn ...